Market Update: Wed, Oct 14, 2020 | LPL Financial Research

Daily Insights

Markets mixed overnight. S&P 500 Index opened little changed after taking a breather yesterday amid noisy headlines around fiscal stimulus and vaccine trials. Asian markets finished mixed with South Korea, China, and Australia trading lower, while European stocks are modestly lower in midday trading. Following a roughly 10% rally since the September low for the S&P 500, it comes as no surprise that markets take a short breather to consolidate the gains.

Mixed elections signals from markets. While performance for the S&P 500 has been strong thus far in the three months leading up to the election—which has historically been a strong indicator for the incumbent party—underlying securities may be pointing another direction. With help from our friends at Strategas Research Partners, we take a look at policy-based portfolios to see what the market may be telling us about the upcoming election in today’s LPL Research blog.

Brexit Update. Negotiations over the United Kingdom’s (UK) withdrawal from the European Union (EU) are continuing as the October 15th deadline, imposed by British Prime Minister Boris Johnson, to reach a wider trade agreement approaches. One key sticking point appears to be EU, specifically French, access to UK fishing waters. While the fishing industry is an emotive subject in the UK, it makes up only 0.12% of the UK’s GDP; therefore, we do not anticipate either side allowing this issue to precipitate a “No-deal” Brexit that could be economically damaging to both sides.

Technical update. Markets sold off yesterday, as both the Dow and S&P 500 fell 0.6%. The Nasdaq outperformed, but still posted a 10 basis point loss after spending most of the day in the green. The S&P 500 closed at 3512, and has short-term tactical support at 3425, about 2.5% below yesterday’s close.

COVID-19 news. New cases in the United States have now risen by double-digit percentages for seven straight days, pushing the seven-day moving average above 51,000 to a two-month high (source: COVID Tracking Project). Hospitalizations continue to inch higher but remain well below the August peaks. New restrictions may be announced in France and Spain today while the UK faces pressure to lock down. Eli Lilly halted its antibody trial due to safety concerns after Johnson & Johnson paused its vaccine trial Tuesday due to an unexpected illness. Pauses and stops in vaccine trials are common, but we are watching the progress very closely.

LPL Research in the Media 

LPL Financial’s Chief Market Strategist Ryan Detrick was featured in MarketWatch to talk about the election.

LPL Research Equity Strategist Jeff Buchbinder was quoted in Yahoo! Finance.

 

IMPORTANT DISCLOSURES

This material is for general information only and is not intended to provide specific advice or recommendations for any individual. There is no assurance that the views or strategies discussed are suitable for all investors or will yield positive outcomes. Investing involves risks including possible loss of principal. Any economic forecasts set forth may not develop as predicted and are subject to change.

References to markets, asset classes, and sectors are generally regarding the corresponding market index. Indexes are unmanaged statistical composites and cannot be invested into directly. Index performance is not indicative of the performance of any investment and do not reflect fees, expenses, or sales charges. All performance referenced is historical and is no guarantee of future results.

Any company names noted herein are for educational purposes only and not an indication of trading intent or a solicitation of their products or services. LPL Financial doesn’t provide research on individual equities.

All information is believed to be from reliable sources; however, LPL Financial makes no representation as to its completeness or accuracy.

All index and market data are from FactSet and MarketWatch.

This Research material was prepared by LPL Financial, LLC.

Securities and advisory services offered through LPL Financial (LPL), a registered investment advisor and broker-dealer (member FINRA/SIPC).

Insurance products are offered through LPL or its licensed affiliates.  To the extent you are receiving investment advice from a separately registered independent investment advisor that is not an LPL affiliate, please note LPL makes no representation with respect to such entity.

  • Not Insured by FDIC/NCUA or Any Other Government Agency
  • Not Bank/Credit Union Guaranteed
  • Not Bank/Credit Union Deposits or Obligations
  • May Lose Value

For Public Use – Tracking 1-05067192